• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人工智能在药物警戒中的应用:考虑范围要点。

Artificial Intelligence in Pharmacovigilance: Scoping Points to Consider.

机构信息

Safety Sciences Research, Pfizer Inc, New York, NY, USA; Department of Medicine, NYU Langone Health, New York, NY, USA.

Pharmaceutical Physician, Kent, United Kingdom.

出版信息

Clin Ther. 2021 Feb;43(2):372-379. doi: 10.1016/j.clinthera.2020.12.014. Epub 2021 Jan 18.

DOI:10.1016/j.clinthera.2020.12.014
PMID:33478803
Abstract

Artificial intelligence (AI), a highly interdisciplinary science, is an increasing presence in pharmacovigilance (PV). A better understanding of the scope of artificial intelligence in pharmacovigilance (AIPV) may be advantageous to more sharply defining, for example, which terms, methods, tasks, and data sets are suitably subsumed under the application of AIPV. Accordingly, this article explores relevant points to consider regarding defining the scope of AIPV and offers a potential working definition of the scope of AIPV.

摘要

人工智能(AI)是一门高度交叉的科学,在药物警戒(PV)中越来越常见。更好地了解人工智能在药物警戒中的应用(AIPV)的范围,可能有助于更准确地定义,例如,哪些术语、方法、任务和数据集适合归入 AIPV 的应用范围。因此,本文探讨了定义 AIPV 范围时需要考虑的相关要点,并提出了 AIPV 范围的潜在工作定义。

相似文献

1
Artificial Intelligence in Pharmacovigilance: Scoping Points to Consider.人工智能在药物警戒中的应用:考虑范围要点。
Clin Ther. 2021 Feb;43(2):372-379. doi: 10.1016/j.clinthera.2020.12.014. Epub 2021 Jan 18.
2
Artificial Intelligence Within Pharmacovigilance: A Means to Identify Cognitive Services and the Framework for Their Validation.药物警戒中的人工智能:一种识别认知服务及其验证框架的方法。
Pharmaceut Med. 2019 Apr;33(2):109-120. doi: 10.1007/s40290-019-00269-0.
3
Artificial Intelligence Based on Machine Learning in Pharmacovigilance: A Scoping Review.基于机器学习的药物警戒人工智能:范围综述。
Drug Saf. 2022 May;45(5):477-491. doi: 10.1007/s40264-022-01176-1. Epub 2022 May 17.
4
What place for intelligent automation and artificial intelligence to preserve and strengthen vigilance expertise in the face of increasing declarations?面对日益增多的声明,智能自动化和人工智能在维护和加强警惕性专业技能方面能发挥什么作用?
Therapie. 2023 Jan-Feb;78(1):131-143. doi: 10.1016/j.therap.2022.11.004. Epub 2022 Nov 25.
5
Artificial Intelligence and the Future of the Drug Safety Professional.人工智能与药物安全专业人士的未来。
Drug Saf. 2019 Apr;42(4):491-497. doi: 10.1007/s40264-018-0746-z.
6
The Use of Artificial Intelligence in Pharmacovigilance: A Systematic Review of the Literature.人工智能在药物警戒中的应用:文献系统评价。
Pharmaceut Med. 2022 Oct;36(5):295-306. doi: 10.1007/s40290-022-00441-z. Epub 2022 Jul 29.
7
Artificial Intelligence in Pharmacovigilance: An Introduction to Terms, Concepts, Applications, and Limitations.人工智能在药物警戒学中的应用:术语、概念、应用和局限性介绍。
Drug Saf. 2022 May;45(5):407-418. doi: 10.1007/s40264-022-01156-5. Epub 2022 May 17.
8
Industry Perspective on Artificial Intelligence/Machine Learning in Pharmacovigilance.药物警戒人工智能/机器学习的行业视角。
Drug Saf. 2022 May;45(5):439-448. doi: 10.1007/s40264-022-01164-5. Epub 2022 May 17.
9
Will the future of pharmacovigilance be more automated?药物警戒的未来会更加自动化吗?
Expert Opin Drug Saf. 2023 Jul-Dec;22(7):541-548. doi: 10.1080/14740338.2023.2227091. Epub 2023 Jul 12.
10
"Artificial Intelligence" for Pharmacovigilance: Ready for Prime Time?"人工智能"在药物警戒中的应用:是否已经准备好投入使用?
Drug Saf. 2022 May;45(5):429-438. doi: 10.1007/s40264-022-01157-4. Epub 2022 May 17.

引用本文的文献

1
The promises and perils of artificial intelligence in clinical medicine: a dual perspective from internal medicine and pediatrics.临床医学中人工智能的前景与风险:来自内科和儿科的双重视角
Croat Med J. 2025 Aug 31;66(4):243-246. doi: 10.3325/cmj.2025.66.243.
2
Artificial intelligence in pharmacovigilance: advancing drug safety monitoring and regulatory integration.药物警戒中的人工智能:推进药物安全监测与监管整合
Ther Adv Drug Saf. 2025 Jul 31;16:20420986251361435. doi: 10.1177/20420986251361435. eCollection 2025.
3
Leveraging Natural Language Processing and Machine Learning Methods for Adverse Drug Event Detection in Electronic Health/Medical Records: A Scoping Review.
利用自然语言处理和机器学习方法在电子健康/医疗记录中进行药物不良事件检测:一项范围综述
Drug Saf. 2025 Apr;48(4):321-337. doi: 10.1007/s40264-024-01505-6. Epub 2025 Jan 9.
4
Artificial intelligence integration in the drug lifecycle and in regulatory science: policy implications, challenges and opportunities.人工智能在药物生命周期和监管科学中的整合:政策影响、挑战与机遇。
Front Pharmacol. 2024 Aug 2;15:1437167. doi: 10.3389/fphar.2024.1437167. eCollection 2024.
5
Integrating machine learning with electronic health record data to facilitate detection of prolactin level and pharmacovigilance signals in olanzapine-treated patients.将机器学习与电子健康记录数据相结合,以帮助检测奥氮平治疗患者的催乳素水平和药物警戒信号。
Front Endocrinol (Lausanne). 2022 Oct 13;13:1011492. doi: 10.3389/fendo.2022.1011492. eCollection 2022.
6
Artificial Intelligence-Based Pharmacovigilance in the Setting of Limited Resources.基于人工智能的有限资源药物警戒。
Drug Saf. 2022 May;45(5):511-519. doi: 10.1007/s40264-022-01170-7. Epub 2022 May 17.
7
Industry Perspective on Artificial Intelligence/Machine Learning in Pharmacovigilance.药物警戒人工智能/机器学习的行业视角。
Drug Saf. 2022 May;45(5):439-448. doi: 10.1007/s40264-022-01164-5. Epub 2022 May 17.
8
Identifying Actionability as a Key Factor for the Adoption of 'Intelligent' Systems for Drug Safety: Lessons Learned from a User-Centred Design Approach.确定可操作性是采用“智能”药物安全系统的关键因素:从以用户为中心的设计方法中获得的经验教训。
Drug Saf. 2021 Nov;44(11):1165-1178. doi: 10.1007/s40264-021-01103-w. Epub 2021 Oct 21.
9
Big data, medicines safety and pharmacovigilance.大数据、药品安全与药物警戒
J Pharm Policy Pract. 2021 Jun 2;14(1):48. doi: 10.1186/s40545-021-00329-4.